Mechanism of action
Citric acid is a tricarboxylic acid that undergoes hepatic metabolism via the Krebs cycle, generating three bicarbonate ions per molecule. This systemic alkalinization raises blood pH and increases the filtered load of bicarbonate at the renal tubule, elevating urine pH.
Urinary alkalinization
By increasing urine pH above 6.5, citric acid enhances the solubility of uric acid and cystine, preventing precipitation and stone formation. Alkaline urine shifts the equilibrium of uric acid (pKa ~5.4) toward its more soluble urate form.
Calcium chelation
Citrate ions bind calcium in solution, forming soluble complexes that inhibit calcium oxalate and calcium phosphate crystal nucleation and aggregation. This is the primary mechanism by which citrate reduces calcium stone recurrence.
Anticoagulant effect
In blood collection systems, citric acid chelates ionized calcium, preventing the coagulation cascade. Citrate-phosphate-dextrose (CPD) and acid-citrate-dextrose (ACD) solutions are standard anticoagulants for blood banking.
- Each millimole of citrate yields 3 mEq bicarbonate (1 mEq citrate = 1 mEq bicarbonate)
- Urinary citrate inhibits calcium oxalate crystal formation by chelating calcium
- First-line for recurrent calcium stones with hypocitraturia (<320 mg/day)
- Target urine pH 6.5–7.0; above 7.0 favors calcium phosphate stone formation
- Contraindicated in UTI with urease-producing organisms (alkaline urine worsens struvite stones)
- Potassium citrate is preferred over sodium citrate to avoid hypercalciuria
- Citrate enhances aluminum absorption; avoid in renal failure patients on aluminum antacids
- Citrate toxicity in massive transfusion causes hypocalcemia, tetany, and arrhythmia
Indications
Nephrolithiasis prophylaxis — Primary indication for recurrent calcium oxalate, uric acid, and cystine stones. Citrate supplementation is first-line in hypocitraturia.
Renal tubular acidosis — Type 1 (distal) RTA causes systemic acidosis and hypocitraturia; citrate corrects both and prevents nephrocalcinosis.
Metabolic acidosis — Citric acid (or its salts) provides alkali therapy in chronic metabolic acidosis when sodium or potassium citrate is better tolerated than bicarbonate.
Urinary alkalinization — Used off-label to enhance renal excretion of weak acids such as methotrexate or salicylates in overdose settings.
Blood anticoagulation — Citrate solutions preserve blood products for transfusion and are used in apheresis and dialysis circuits.
Pharmaceutical excipient — Citric acid serves as a buffering, flavoring, and effervescent agent in many oral formulations.
Pharmacokinetics
| Parameter | Value |
|---|---|
| Absorption | Rapid from GI tract; bioavailability ~100% |
| Distribution | Enters systemic circulation; does not concentrate in tissues |
| Metabolism | Complete oxidation in mitochondria via Krebs cycle to CO₂ and H₂O |
| Excretion | Metabolic end products exhaled as CO₂; minimal renal excretion of parent compound |
| Half-life | Not applicable; citrate is fully metabolized within hours |
Key points — Citric acid and its salts are prodrugs that generate bicarbonate. Each millimole of citrate yields 3 mEq of bicarbonate after metabolism (1 mEq citrate = 1 mEq bicarbonate). The onset of urinary alkalinization occurs within 1–2 hours of oral dosing. Citrate excretion in urine depends on dietary intake and renal tubular reabsorption; systemic alkalosis reduces citrate reabsorption and increases urinary citrate.
Citric acid solutions are absorbed more rapidly than solid formulations. Concurrent food intake does not significantly alter absorption but may reduce GI side effects.
Adverse effects
Gastrointestinal
- Nausea and vomiting — Most common; related to osmotic load and acidity
- Diarrhea — Osmotic effect; dose-dependent
- Abdominal cramping and bloating
Metabolic
- Metabolic alkalosis — Excessive dosing or impaired renal function
- Hypernatremia or hyperkalemia — Depends on the cation (sodium citrate vs. potassium citrate)
- Hypocalcemia — Rare; chelation may transiently lower ionized calcium
Renal
- Calcium phosphate stones — Paradoxical risk if urine pH exceeds 7.0; alkaline urine favors calcium phosphate precipitation
Cardiovascular
- Citrate toxicity — In massive transfusion or rapid infusion (dialysis, apheresis); ionized calcium falls, causing perioral numbness, tetany, arrhythmia, and hypotension
Other
- Dental erosion — Prolonged contact with acidic citrate solutions
- Aluminum absorption — Citrate enhances GI aluminum absorption; significant in renal failure patients on aluminum-containing antacids
Contraindications and warnings
Contraindications
- Severe renal impairment with oliguria or anuria
- Hyperkalemia (for potassium citrate formulations)
- Active urinary tract infection with urease-producing organisms (e.g., Proteus)
- Peptic ulcer disease (citric acid may worsen mucosal irritation)
Warnings
- Renal insufficiency — Risk of metabolic alkalosis and electrolyte disturbances; dose adjustment required
- Heart failure or edema — Sodium citrate increases sodium load; use potassium citrate if indicated
- Potassium-sparing states — Risk of hyperkalemia with potassium citrate in patients on ACE inhibitors, ARBs, or potassium-sparing diuretics
- Chronic diarrhea or malabsorption — May worsen fluid and electrolyte losses
Pregnancy and lactation — Citric acid and citrate salts are generally considered safe (Pregnancy Category C historically; low systemic risk). Citrate is a normal dietary component and is present in breast milk.
Drug interactions
Aluminum-containing compounds — Citrate increases GI absorption of aluminum; avoid concurrent use in renal failure (risk of aluminum toxicity and encephalopathy).
Anticholinergics — Slow gastric emptying may increase citrate exposure and GI side effects.
Potassium-sparing diuretics and RAAS inhibitors — Concurrent use with potassium citrate raises hyperkalemia risk; monitor serum potassium closely.
Urinary pH-dependent drugs — Alkalinization alters renal clearance of weak acids and bases:
- Enhanced excretion — Salicylates, methotrexate, phenobarbital (weak acids become ionized and trapped in alkaline urine)
- Reduced excretion — Amphetamines, quinidine, ephedrine (weak bases are reabsorbed)
Sodium chloride — High dietary sodium increases urinary calcium excretion, partially offsetting the benefit of citrate therapy.
Calcium supplements — Citrate enhances calcium absorption; useful in osteoporosis but may increase risk of hypercalciuria and stone formation in susceptible patients.
Clinical pearls
- First-line for hypocitraturia — Urinary citrate <320 mg/day is a strong risk factor for calcium stones; citrate supplementation reduces recurrence by 50–70%.
- Target urine pH — For uric acid and cystine stones, aim for pH 6.5–7.0; above 7.0 risks calcium phosphate stones.
- Sodium vs. potassium citrate — Prefer potassium citrate in most patients; sodium citrate increases urinary calcium excretion and may worsen hypercalciuria.
- Citrate in RTA — Distal RTA causes acidosis, hypercalciuria, hypocitraturia, and nephrocalcinosis; lifelong citrate therapy is essential.
- Citrate toxicity in transfusion — Rapid infusion of citrated blood (>1 unit per 5 minutes) can cause hypocalcemia; monitor ionized calcium during massive transfusion protocol.
- Struvite stones — Do not use citrate in infection stones with urease-producing bacteria (Proteus, Klebsiella); these organisms split urea into ammonia, creating alkaline urine that worsens struvite precipitation.
- Potassium citrate is preferred over potassium chloride — In hypokalemia with metabolic acidosis, potassium citrate corrects both simultaneously; potassium chloride alone does not address acidosis.
- Liquid vs. tablet — Liquid formulations are absorbed faster but have shorter shelf life and worse taste; extended-release tablets (e.g., Urocit-K) reduce GI side effects and improve adherence.
CITRATE for mechanism and uses: Chelates Calcium, Inhibits stones, Tricarboxylate → 3 bicarbonates, RTA therapy, Alkalinizes urine, Transfusion anticoagulant, Enhances solubility (uric acid/cystine)
Practice questions
1. A 45-year-old man with a history of recurrent calcium oxalate kidney stones is found to have a 24-hour urinary citrate excretion of 250 mg (normal >320 mg/day). His serum potassium is 3.2 mEq/L, and he has no history of heart failure. Which of the following is the most appropriate pharmacologic intervention?
2. A 62-year-old woman undergoing apheresis for hyperviscosity syndrome develops perioral numbness, paresthesias, and a prolonged QT interval on ECG. Vital signs show blood pressure 110/70 mmHg and heart rate 95/min. Serum studies reveal total calcium 9.0 mg/dL (normal 8.5–10.5) and ionized calcium 0.9 mmol/L (low; normal 1.1–1.4). Which of the following is the most likely cause?
3. A 50-year-old man with chronic kidney disease stage 4 and peptic ulcer disease is on aluminum hydroxide for phosphate control. His nephrologist starts potassium citrate for recurrent uric acid stones. Two weeks later, he develops confusion, myoclonus, and speech difficulty. Which of the following best explains his presentation?
Frequently asked questions
How does citric acid work to prevent kidney stones?
Citric acid is metabolized to bicarbonate, which alkalinizes urine and increases urinary citrate excretion. Citrate chelates calcium, preventing calcium oxalate and calcium phosphate crystal formation. Alkaline urine also increases the solubility of uric acid and cystine, preventing their precipitation into stones.
What are the side effects of citric acid?
The most common side effects are gastrointestinal: nausea, diarrhea, and abdominal cramping due to osmotic effects. Metabolic alkalosis can occur with excessive dosing. Potassium citrate may cause hyperkalemia, and sodium citrate may worsen hypertension or edema. Citrate enhances aluminum absorption, raising toxicity risk in renal failure. Rapid intravenous citrate (e.g., in transfusion) can cause hypocalcemia.
Is citric acid safe during pregnancy?
Citric acid and citrate salts are generally considered safe during pregnancy. Citrate is a normal dietary component and metabolic intermediate. There are no well-documented teratogenic effects. However, as with any medication, it should be used only when clearly indicated, and potassium citrate should be avoided in patients with hyperkalemia or severe renal impairment.
Citric acid vs sodium bicarbonate — what is the difference?
Citric acid is a prodrug that generates bicarbonate after hepatic metabolism, while sodium bicarbonate provides immediate alkali. Citric acid increases urinary citrate levels, which directly inhibit calcium stone formation; bicarbonate does not. Sodium bicarbonate may cause more rapid alkalinization but increases sodium load and urinary calcium excretion. Citrate is preferred for nephrolithiasis; bicarbonate is used for acute metabolic acidosis.
Can citric acid cause kidney stones?
Citric acid prevents most kidney stones by increasing urinary citrate and pH. However, if urine pH rises above 7.0, calcium phosphate stones may form paradoxically because calcium phosphate is less soluble in alkaline urine. Additionally, citrate should not be used in patients with struvite (infection) stones caused by urease-producing bacteria, as alkaline urine worsens their formation.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A09AB04
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.